ArticleACS omega2025
Study on an Electrochemical Immunosensor for Sensitive Detection of Myoglobin Based on Graphene-Nanogold Composite Material.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute myocardial infarction (AMI) is a highly lethal cardiovascular emergency, and early diagnosis is crucial for improving prognosis. Myoglobin (Mb), as an early biomarker, is of great significance for rapid and sensitive detection. Traditional methods rely on electrocardiography (ECG) and clinical symptom assessment, which can lead to misdiagnosis or delayed treatment due to atypical features. This study developed an electrochemical immunosensor based on graphene-nanogold composite materials (GR-AuNPs) for highly sensitive detection of Mb. The electrochemical performance was analyzed by CV, EIS, and DPV, and the material was characterized by SEM and EDS. The sensor exhibits good linear response within the concentration range of 0.001-100 ng/mL Mb, with a detection limit as low as 0.42 pg/mL (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.